Mr. Raj Grover reports

HIGH TIDE ANNOUNCES PURCHASES OF SHARES BY INSIDERS

Certain officers, directors and consultants, led by High Tide Inc.'s president and chief executive officer (together, the insiders), in the aggregate, acquired 90,882 common shares in the capital of High Tide on the open market between May 6, 2026, and May 8, 2026, at an average price of $3.39 per common share. The purchase of common shares by the insiders reflects confidence in the intrinsic value of the stock, and the near-term and long-term growth prospects of the company. With these purchases, insiders and certain consultants, in the aggregate, now own or control 7,720,360 common shares, representing approximately 8.8 per cent of the company's issued and outstanding common shares as of today.

"Over the last week, High Tide has continued to demonstrate why we believe we are one of the strongest operators in the global cannabis industry. We secured a new senior lending relationship with a Big 5 Canadian bank through a $40-million credit facility term sheet, reported record quarterly medical cannabis distribution volumes at Remexian and completed a highly productive institutional investor road show across three cities. In addition, newly released BfArM Q1 2026 data indicates that Remexian's market share in Germany has risen to over 14 per cent, more than doubling its share since our transaction, and further validating the strength of our international strategy," said Raj Grover, founder and chief executive officer of High Tide.

"I am very pleased to have increased my own ownership position alongside several members of our board and leadership team following these developments. We believe the operational momentum across our retail platform, international business and balance sheet continues to strengthen, and these insider purchases reflect our confidence in the long-term value we are building," added Mr. Grover.

About High Tide Inc.

High Tide is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide is uniquely built around the cannabis consumer, with wholly diversified and fully integrated operations across all components of cannabis, including:

• Retail: Canna Cabana is the largest cannabis retail chain in Canada, with 221 domestic locations and one international location. The company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, holding a growing 12-per-cent share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.
• Medical cannabis distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked No. 1 in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023.

We seek Safe Harbor.